Therapeutic Asset Ratings
18,153 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Trametinib
Anaplastic Ganglioglioma
National Cancer Institute (NCI)
P4
BB
(69)
Trametinib
Anaplastic Oligodendroglioma
Novartis Pharmaceuticals
P4
BB
(69)
Trametinib
Anaplastic Pleomorphic Xanthoastrocytoma
National Cancer Institute (NCI)
P4
BB
(69)
Trametinib
Melanoma
Xynomic Pharmaceuticals, Inc.
P4
BB
(69)
Triamcinolone Hexacetonide
Osteoarthritis
Kastamonu University
P4
BB
(69)
Triamcinolone Hexacetonide
Osteoarthritis, Knee
Kastamonu University
P4
BB
(69)
Trimetazidine
Mitochondrial Disease
Steen Hvitfeldt Poulsen
P4
BB
(69)
Tucidinostat
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Ruijin Hospital
P4
BB
(69)
Umbellatine
Abdominal Obesity-Metabolic Syndrome
Nanjing First Hospital, Nanjing Medical University
P4
BB
(69)
Umbellatine
Metabolic Dysfunction-Associated Steatotic Liver Disease
China National Center for Cardiovascular Diseases
P4
BB
(69)
Valsartan
Essential Hypertension
ARKAY Therapeutics
P4
BB
(69)
Vandazole
Colorectal Neoplasm
Helsinki University Central Hospital
P4
BB
(69)
Varinon
Post-Operative Wound Seroma, Non-Human Animal
Ittefaq Hospital trust
P4
BB
(69)
Venetoclax
Acute Myeloid Leukemia
European Organisation for Research and Treatment of Cancer - EORTC
P4
BB
(69)
(+)-Vincristine
Angioimmunoblastic T-Cell Lymphoma
Shanghai Jiao Tong University School of Medicine
P4
BB
(69)
(+)-Vincristine
B-Cell Non-Hodgkin Lymphoma
Mwanasha Merrill, MD
P4
BB
(69)
(+)-Vincristine
Metastatic Neoplasm
Eli Lilly and Company
P4
BB
(69)
Vortioxetine
Bipolar Depression
Mayo Clinic
P4
BB
(69)
Xaliplatin
Colorectal Carcinoma
First Affiliated Hospital of Zhejiang University
P4
BB
(69)
Zonisamide
Epilepsy
Azurity Pharmaceuticals
P4
BB
(69)
4,5,7,4',5',7'-HEXAHYDROXY-2,2'-DIMETHYLNAPHTHODIANTHRONE
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Soligenix
P3
BB
(69)
Adriamycin
Hodgkin'S Lymphoma, Mixed Cellularity
National Cancer Institute (NCI)
P3
BB
(69)
Adriamycin
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)
P3
BB
(69)
Adriamycin
Hodgkin'S Lymphoma, Lymphocytic Depletion
National Cancer Institute (NCI)
P3
BB
(69)
Adriamycin
Ovarian Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
P3
BB
(69)
Showing 1451 to 1475 of 18,153 assets
Previous
Page 59 of 727
Next